Pharmaceutical Business Review
Return to: PBR Home | Suppliers

NSF: Global Selection Considerations for CMO When Conducting Due Diligence

Published 03 November 2017 | By NSF International

Deciding to use a CMO requires a thorough due diligence exercise conducted both as desktop and on-site reviews. This NSF white paper by Maxine Fritz provides the fundamental factors to consider when engaging and deciding on a CMO.

Available Downloads

NSF: Global Selection Considerations for CMO When Conducting Due Diligence